Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NA 11. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110452150A reveals mild chiral phosphoric acid catalysis. Enables cost reduction in fine chemical intermediates manufacturing with high enantioselectivity.
Patent CN118619879A details efficient Rh-catalyzed synthesis. Offers high purity intermediates and scalable processes for global pharmaceutical supply chains.
Patent CN118619879A reveals a Rhodium-catalyzed route for trifluoromethyl enaminones, offering cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN112321593B details a novel cobalt-catalyzed carbonylation route for indolo[1,2-a]quinazolin-6(5H)-ones, offering a cost-effective alternative to palladium methods for pharmaceutical intermediates.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering high yields and broad substrate scope for efficient API manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid catalysis. Offers high ee, mild conditions, and scalable production for pharmaceutical applications.
Advanced HDDA reaction pathway for complex naphthalene derivatives offering high atom economy and scalable production for pharmaceutical and agrochemical applications.
Patent CN110183378A reveals high-yield catalytic route for nicotinamide derivatives ensuring supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel Rh-catalyzed method for trifluoromethyl enaminones. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN114989063B reveals a novel Pd-catalyzed tandem cyclization for beta-halogenated pyrroles, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN115636829B reveals efficient rhodium catalysis for trifluoromethyl benzo naphthyridine. Enables high-purity OLED material manufacturing with scalable supply chain advantages.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for API manufacturing.
Novel rhodium-catalyzed method ensures high-purity OLED material intermediates with scalable supply chain efficiency and significant cost reduction.
Patent CN115636829B reveals a rhodium-catalyzed route for high-purity organic luminescent materials, offering significant cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN115636829B reveals a Rh-catalyzed route for high-purity benzo[1,8]naphthyridine compounds, offering cost reduction and scalable manufacturing for optoelectronic applications.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates using cheap nitro compounds.
Patent CN116478052B reveals copper-catalyzed synthesis for high-purity 1-naphthylamine derivatives. Offers scalable production and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN118619879A reveals a novel Rh-catalyzed route for high-purity trifluoromethyl enaminones, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118619879A reveals a novel Rh-catalyzed method for trifluoromethyl enaminones. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable processes.